SELECTIVE ELIMINATION OF CD133+ CANCER STEM CELLS AS THERAPY FOR PDAC USING NOVELDUAL BET/HDAC INHIBITOR TW09

Kanishka Tiwary  ¹     Selina Mader  ¹     Stefanie Hauff  ¹     Arijan Valar  ¹     Tabea Ditrich  ¹     Xin Zhang  ²     Eva Rodriguez-Aznar  ²     Alexander Kleger  ²     Thomas Seufferlein  ²     Bruno Sainz Jr.  ³     Stephan A. Hahn  ⁴     Steven A. Johnsen  ⁵     Stefan Knapp  ⁶     Jens T. Siveke  ⁶     Karolin Walter  ⁶     Patrick Christian Hermann  ^6    
1 University Ulm, Ulm, Germany
² West German Cancer Center, University Medicine Essen, Essen, Germany
³ Instituto de Investigaciones Biomédicas "Alberto Sols" (IIBM), CSIC-UAM, Madrid, Germany
⁴ Knappschaftskrankenhaus Bochum, Ruhr-University of Bochum, Bochum, Bochum, Germany
⁵ University Medical Center Göttingen, Göttingen, Germany
⁶ Goethe University Frankfurt, Frankfurt, Frankfurt, Germany

Topic
Pancreas

Session
Basic science in pancreatic disease

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)